Pharmaceutical Distribution DX Startup 9lione Raises 120 Million Yen in Series A, Bringing Total Funding to 440 Million Yen
Overview of Funding
9lione Inc. has raised a total of 120 million yen in a Series A round led by Yokohama Capital. This brings the company's cumulative funding to 440 million yen, including investments from existing backers and debt financing. Additionally, as part of its Series A extension, the company has initiated a campaign through the equity-type crowdfunding platform "FUNDINNO."
9lione: A DX Platform for Pharmaceutical Distribution
"9lione" is a platform that redistributes surplus pharmaceutical inventory from medical institutions and pharmacies to facilities in need. By acquiring a pharmaceutical wholesale license and managing everything from quality control to delivery in-house, the company ensures traceability compliant with GDP (Good Distribution Practice) guidelines. This enables medical facilities to monetize medications that would otherwise be discarded as waste, while improving liquidity for hard-to-source pharmaceuticals.
Purpose of Funding and Future Outlook
Funds raised in this round will be allocated toward expanding the company's network of operational bases to serve medical institutions nationwide, developing AI-powered inventory visualization and automated trading features, and strengthening the organizational structure. Moving forward, 9lione aims to accelerate its role as a critical social infrastructure that reduces inventory burdens in medical settings and ensures a stable supply of drugs through advanced supply-demand forecasting capabilities.
List of Underwriters (Investors)
- Yokohama Capital (Lead Investor)
- Incubate Fund
- DG Ventures
- MS&AD Ventures (Mitsui Sumitomo Insurance Capital)
- Globe Advisors
- NanoBank
- Other angel investors